Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Impairment of Executive Functions Associated With Lower D-Serine Serum Levels in Patients With Schizophrenia

J. Hons, R. Zirko, M. Vasatova, P. Doubek, B. Klimova, J. Masopust, M. Valis, K. Kuca

. 2021 ; 12 (-) : 514579. [pub] 20210329

Language English Country Switzerland

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc21018073

A core symptom that is frequently linked with dysregulation of glutamatergic neurotransmission in regard to schizophrenia is impairment or damage of executive functioning as a component of cognitive deficiency. The amino acid D-serine plays the role of an endogenous coagonist at the glutamatergic N-methyl-D-aspartate (NMDA) receptor glycine modulatory site. Considerably reduced serum levels of D-serine were found in patients suffering from schizophrenia compared with healthy control participants. An increase in D-serine led to augmented cognitive functionality in patients suffering from schizophrenia who were undergoing clinical trials and given the treatment of first- and second-generation antipsychotics. The study proposed the hypothesis that the D-serine blood serum levels may be linked with the extent of executive functionality in those suffering from the mental illness in question. For the purpose of examining executive function in such patients, the Rey-Osterrieth Complex Figure, Trail Making, and Wisconsin Card Sorting tests were applied (n = 50). High-performance liquid chromatography was used to gauge the total serine and D-serine levels. The extent of damage was examined through neuropsychological tests and was found to be considerably linked to D-serine serum level and the D-serine/total serine ratio (p < 0.05) in the sample being considered. A lower average serum level of D-serine and lower D-serine/total serine ratio were observed in participants with the worst performance compared with those displaying the best performance-this was true when the patients were split into quartile groups based on their results (p < 0.05). The findings of modified D-serine serum levels and the D-serine/total serine ratio linked to the extent of damage in executive functioning indicate that serine metabolism that is coresponsible for NMDA receptor dysfunction has been changed.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21018073
003      
CZ-PrNML
005      
20240723093738.0
007      
ta
008      
210726e20210329sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fpsyt.2021.514579 $2 doi
035    __
$a (PubMed)33854443
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Hons, Jaromir $u Center for Psychiatry, Regional Hospital Liberec, Liberec, Czechia $u Institute of Health Studies, Technical University of Liberec, Liberec, Czechia
245    10
$a Impairment of Executive Functions Associated With Lower D-Serine Serum Levels in Patients With Schizophrenia / $c J. Hons, R. Zirko, M. Vasatova, P. Doubek, B. Klimova, J. Masopust, M. Valis, K. Kuca
520    9_
$a A core symptom that is frequently linked with dysregulation of glutamatergic neurotransmission in regard to schizophrenia is impairment or damage of executive functioning as a component of cognitive deficiency. The amino acid D-serine plays the role of an endogenous coagonist at the glutamatergic N-methyl-D-aspartate (NMDA) receptor glycine modulatory site. Considerably reduced serum levels of D-serine were found in patients suffering from schizophrenia compared with healthy control participants. An increase in D-serine led to augmented cognitive functionality in patients suffering from schizophrenia who were undergoing clinical trials and given the treatment of first- and second-generation antipsychotics. The study proposed the hypothesis that the D-serine blood serum levels may be linked with the extent of executive functionality in those suffering from the mental illness in question. For the purpose of examining executive function in such patients, the Rey-Osterrieth Complex Figure, Trail Making, and Wisconsin Card Sorting tests were applied (n = 50). High-performance liquid chromatography was used to gauge the total serine and D-serine levels. The extent of damage was examined through neuropsychological tests and was found to be considerably linked to D-serine serum level and the D-serine/total serine ratio (p < 0.05) in the sample being considered. A lower average serum level of D-serine and lower D-serine/total serine ratio were observed in participants with the worst performance compared with those displaying the best performance-this was true when the patients were split into quartile groups based on their results (p < 0.05). The findings of modified D-serine serum levels and the D-serine/total serine ratio linked to the extent of damage in executive functioning indicate that serine metabolism that is coresponsible for NMDA receptor dysfunction has been changed.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Zirko, Rastislav $u Department of Psychiatry, Faculty of Medicine in Hradec Kralove, University Hospital Hradec Kralove and Charles University in Prague, Hradec Kralove, Czechia
700    1_
$a Vasatova, Martina $u Institute of Clinical Biochemistry and Diagnostics, University Hospital Hradec Kralove and Charles University in Prague, Hradec Kralove, Czechia
700    1_
$a Doubek, Pavel, $d 1970- $u Department of Psychiatry, 1st Faculty of Medicine, General Teaching Hospital and Charles University in Prague, Prague, Czechia $7 nlk20030127577
700    1_
$a Klimova, Blanka $u Department of Neurology, Faculty of Medicine in Hradec Kralove, University Hospital Hradec Kralove and Charles University in Prague, Hradec Kralove, Czechia
700    1_
$a Masopust, Jiri $u Department of Psychiatry, Faculty of Medicine in Hradec Kralove, University Hospital Hradec Kralove and Charles University in Prague, Hradec Kralove, Czechia $u Department of Neurology, Faculty of Medicine in Hradec Kralove, University Hospital Hradec Kralove and Charles University in Prague, Hradec Kralove, Czechia
700    1_
$a Valis, Martin $u Department of Neurology, Faculty of Medicine in Hradec Kralove, University Hospital Hradec Kralove and Charles University in Prague, Hradec Kralove, Czechia
700    1_
$a Kuca, Kamil $u Biomedical Research Center, University Hospital Hradec Kralove, Hradec Kralove, Czechia $u Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czechia
773    0_
$w MED00174602 $t Frontiers in psychiatry $x 1664-0640 $g Roč. 12 (20210329), s. 514579
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33854443 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20210726 $b ABA008
991    __
$a 20240723093735 $b ABA008
999    __
$a ind $b bmc $g 1676529 $s 1138515
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 12 $c - $d 514579 $e 20210329 $i 1664-0640 $m Frontiers in psychiatry $n Front Psychiatry $x MED00174602
LZP    __
$a Pubmed-20210726

Find record

Citation metrics

Archiving options